LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 Dasatinib
3.33
uM
LJP6
 0.2403 0.0153 -0.1009 0.0296
BT-20 Dovitinib
3.33
uM
LJP5
 0.4350 0.0186 0.1820 0.0177
BT-20 Enzastaurin
3.33
uM
LJP5
 1.1387 0.0317 1.1998 0.0437
BT-20 Erlotinib
3.33
uM
LJP5
 0.8931 0.0266 0.8466 0.0361
BT-20 Foretinib
3.33
uM
LJP5
 0.3008 0.0245 -0.0146 0.0548
BT-20 R406
3.33
uM
LJP6
 0.9253 0.0565 0.8951 0.0808
BT-20 Pictilisib
3.33
uM
LJP6
 0.3468 0.0448 0.0559 0.0470
BT-20 Gefitinib
3.33
uM
LJP6
 0.8820 0.0291 0.8306 0.0392
BT-20 Geldanamycin
3.33
uM
LJP5
 0.2609 0.0284 -0.0720 0.0570
BT-20 Geldanamycin
3.33
uM
LJP6
 0.2473 0.0283 -0.0919 0.0575
BT-20 GSK1059615
3.33
uM
LJP5
 0.1365 0.0203 -0.2521 0.0484
BT-20 GSK1059615
3.33
uM
LJP6
 0.1654 0.0193 -0.2095 0.0368
BT-20 GSK1904529A
3.33
uM
LJP6
 0.9477 0.0182 0.9253 0.0252
BT-20 Omipalisib
3.33
uM
LJP6
 0.1647 0.0285 -0.2108 0.0518
BT-20 GSK 690693
3.33
uM
LJP5
 0.5878 0.0286 0.4034 0.0363
BT-20 GW843682X
3.33
uM
LJP6
 0.2481 0.0115 -0.0896 0.0254
BT-20 HG-5-113-01
3.33
uM
LJP5
 0.4834 0.0066 0.2511 0.0229
BT-20 HG-5-88-01
3.33
uM
LJP6
 0.8581 0.0229 0.7948 0.0318
BT-20 Imatinib
3.33
uM
LJP6
 0.9725 0.0222 0.9609 0.0312
BT-20 JNK-9L
3.33
uM
LJP6
 0.3254 0.0706 0.0264 0.0845
BT-20 JW-7-24-1
3.33
uM
LJP6
 0.6868 0.1077 0.5515 0.1479
BT-20 Lapatinib
3.33
uM
LJP6
 0.9450 0.0529 0.9233 0.0767
BT-20 LDN-193189
3.33
uM
LJP5
 0.2866 0.0960 -0.0304 0.1248
BT-20 Linifanib
3.33
uM
LJP6
 1.0070 0.0087 1.0106 0.0129
BT-20 Linsitinib
3.33
uM
LJP5
 0.9261 0.0257 0.8939 0.0362